Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma.
Gohar Shahwar ManzarBrian Sandeep DeChike Osita AbanaSunyoung S LeeMilind JavleAhmed Omar KasebJean-Nicolas VautheyHop Sanderson Tran CaoAlbert C KoongGrace Li SmithCullen M TaniguchiEmma Brey HollidayPrajnan DasEugene Jon KoayEthan Bernard LudmirPublished in: Cancers (2022)
In this first reported experience of RT with modern systemic therapy for HCC, combination therapy is safe and well-tolerated. As a favorable prognosticator, there appears to be faster recovery of ALC among patients who received RT with atezolizumab/bevacizumab.